Andy Fowler

Investigating the effect of TRPV4 inhibition on pulmonary-vascular barrier permeability following segmental endotoxin challenge

Sarah Mole, Anya Harry, Andy Fowler et al. · Pulmonary Pharmacology & Therapeutics · 2020 · 16 citations

Life Sciences, Immunology, Pharmacology +11

Safety and efficacy of tiotropium Respimat versus HandiHaler in patients naive to treatment with inhaled anticholinergics: a post hoc analysis of the TIOSPIR trial

Robert A. Wise, Peter M.A. Calverley, Ronald Dahl et al. · npj Primary Care Respiratory Medicine · 2015 · 15 citations · Full text

Pharmacy, Clinical Sciences, Pharmacotherapy +17

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Novel CRTH2 Antagonist BI 1021958 at Single Oral Doses in Healthy Men and Multiple Oral Doses in Men and Women With Well‐Controlled Asthma

Andy Fowler, Rüdiger Koenen, James Hilbert et al. · The Journal of Clinical Pharmacology · 2017 · 11 citations

Medicine, Pharmacokinetics, Pharmacology +7

Safety and efficacy of tiotropium in patients switching from HandiHaler to Respimat in the TIOSPIR trial

Ronald Dahl, Peter M.A. Calverley, Antonio Anzueto et al. · BMJ Open · 2015 · 10 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +13